Gene · 80339
Papers3,957
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 3,957
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Clinical correlates of CT imaging-derived phenotypes among lean and overweight patients with hepatic steatosis. | Sci Rep | 2024 | 38167550 | PubTator, text mining | PubMed |
| Knocking out Fkbp51 decreases CCl4-induced liver injury through enhancement of mitochondrial function and Parkin activity. | Cell Biosci | 2024 | 38167156 | PubTator, text mining | PubMed |
| Age, BMI, and Type 2 Diabetes Modify the Relationship Between PNPLA3 and Advanced Fibrosis in Children and Adults With NAFLD. | Clin Gastroenterol Hepatol | 2024 | 38145725 | PubTator, text mining | PubMed |
| Disruption of a Plasmodium falciparum patatin-like phospholipase delays male gametocyte exflagellation. | Mol Microbiol | 2024 | 38131156 | PubTator, text mining | PubMed |
| Time-of-day-dependent variation of the human liver transcriptome and metabolome is disrupted in MASLD. | JHEP Rep | 2024 | 38125300 | PubTator, text mining | PubMed |
| Parental History of Type 2 Diabetes Mellitus and PNPLA3 Polymorphism Increase the Risk of Severe Stages of Nonalcoholic Fatty Liver Disease. | Dig Dis Sci | 2024 | 38112841 | PubTator, text mining | PubMed |
| PNPLA3-associated mitochondrial dysfunction. | Nat Genet | 2024 | 38110719 | PubTator, text mining | PubMed |
| Association of liver fibrosis with extrahepatic cancer in steatotic liver disease patients with PNPLA3 I148M GG genotype. | Cancer Sci | 2024 | 38083881 | PubTator, text mining | PubMed |
| The role of lipid droplet associated proteins in inherited human disorders. | FEBS Lett | 2024 | 38016936 | PubTator, text mining | PubMed |
| Correspondence on Letter regarding "Waiting for the changes after the adoption of steatotic liver disease". | Clin Mol Hepatol | 2024 | 38016440 | PubTator, text mining | PubMed |
| Exercise training improves serum biomarkers of liver fibroinflammation in patients with metabolic dysfunction-associated steatohepatitis. | Liver Int | 2024 | 38014619 | PubTator, text mining | PubMed |
| Fatty Acid Esterification as a NASH Therapeutic Target. | Cell Mol Gastroenterol Hepatol | 2024 | 37984466 | PubTator, text mining | PubMed |
| PNPLA3 Risk Allele Association With ALT Response to Semaglutide Treatment. | Gastroenterology | 2024 | 37972824 | PubTator, text mining | PubMed |
| Associations between metabolic hyperferritinaemia, fibrosis-promoting alleles and clinical outcomes in steatotic liver disease. | Liver Int | 2024 | 37971775 | PubTator, text mining | PubMed |
| Letter regarding "Waiting for the changes after the adoption of steatotic liver disease". | Clin Mol Hepatol | 2024 | 37957811 | PubTator, text mining | PubMed |
| Comparing rare variants versus common in the pathogenesis of nonalcoholic fatty liver disease: a whole exome sequencing approach. | J Gastroenterol Hepatol | 2024 | 37939728 | PubTator, text mining | PubMed |
| SIRT5 rs12216101 T>G variant is associated with liver damage and mitochondrial dysfunction in patients with non-alcoholic fatty liver disease. | J Hepatol | 2024 | 37890719 | PubTator, text mining | PubMed |
| Causal association of nonalcoholic fatty liver disease with 22 extrahepatic cancers: A Mendelian randomization study. | Hepatol Res | 2024 | 37877524 | PubTator, text mining | PubMed |
| GPAT1 Deficiency in Mice Modulates NASH Progression in a Model-Dependent Manner. | Cell Mol Gastroenterol Hepatol | 2024 | 37844795 | PubTator, text mining | PubMed |
Taiwan Association for the Study of the Liver-Taiwan Society of Cardiology Taiwan position statement for the management of metabolic dysfunction- associated fatty liver disease and cardiovascular diseases. | Clin Mol Hepatol | 2024 | 37793641 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/80339/papers?page=24